Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P08908 (
5-HT1A
)
5,574
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Three rat lines were selectively bred for high (HDS), random (RDS), or low (
LDS
) hypothermic responses to the specific
5-HT1A
receptor agonist 8-OH-DPAT. Forty-five minutes after 8-OH-DPAT administration (0.5 mg/kg), body temperatures dropped 3-5 degrees C in HDS rats, yet this dose produced only about 1.2 degrees C and 0.7 degree C drops in RDS and
LDS
rats, respectively. To investigate the relationship of body temperature of
5-HT1A
receptor binding sites, autoradiographic analyses of [3H]8-OH-DPAT binding to
5-HT1A
receptors in brains of these rats were conducted. Significant differences in binding were found in specific limbic cortical projection sites, with the HDS line having the greatest density of sites. Body temperature responses correlated significantly with [3H]8-OH-DPAT receptor binding in only a few areas of frontal cortex. Binding in many other brain regions, including the anterior and posterior hypothalami (regions long associated with body temperature regulation) and the raphe showed no significant differences among the lines. [3H]Ketanserin binding to cortical 5-HT2 receptors did not differ among the lines, except in the cingulate and superficial frontal cortices where HDS exhibited higher binding. These data suggest that differences in
5-HT1A
receptor number may contribute to the exaggerated hypothermic response to 8-OH-DPAT in HDS rats. These studies also suggest that genetic regulation of receptor density may be brain region specific which should encourage future studies of the mechanisms of
5-HT1A
receptor activity in brain and the action of drugs affecting this receptor.
...
PMID:Brain 5-HT1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity. 951 43
This article reviews published reports and presents new evidence that support a number of commonalties between lines of rats selectively bred for differences in cholinergic (muscarinic) and serotonergic (
5-HT1A
) sensitivity. The Flinders Sensitive Line (FSL) rat, a genetic animal model of depression derived for cholinergic supersensitivity, is more sensitive to both cholinergic and serotonergic agonists, and exhibits exaggerated immobility in the forced swim test relative to the control, Flinders Resistant Line (FRL), rat. Similar exaggerated responses are seen in a line of rats recently selected for increased sensitivity to the
5-HT1A
agonist, 8-OH-DPAT (High DPAT Sensitive--HDS), relative to lines selectively bred for either low (Low DPAT Sensitive--
LDS
) or random (Random DPAT Sensitive--RDS) sensitivity to 8-OH-DPAT. For both the FSL and HDS rats, their exaggerated immobility in the forced swim test is reduced following chronic treatment with antidepressants. The present studies examined further the interaction between cholinergic and serotonergic systems in the above lines. Supersensitive hypothermic responses to 8-OH-DPAT were observed very early (postnatal day 18) in FSL rats, suggesting that both muscarinic and serotonergic supersensitivity are inherent characteristics of these rats. Scopolamine, a muscarinic antagonist, completely blocked the hypothermic effects of the muscarinic agonist oxotremorine in FSL and FRL rats, but had no effect on the hypothermic responses to 8-OH-DPAT, suggesting an independence of muscarinic and
5-HT1A
systems. On the other hand, genetic selection of genetically heterogeneous rats for differential hypothermic responses to the muscarinic agonist oxotremorine were accompanied by differential hypothermic responses to 8-OH-DPAT, suggesting an interaction between muscarinic and
5-HT1A
systems. Overall, these studies argue for an inherent interaction between muscarinic and
5-HT1A
systems, which probably occurs beyond the postsynaptic receptors, possibly at the level of G proteins.
...
PMID:Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. 958 31
Selective breeding for high and low sensitivity to the hypothermic response of the
5-HT1A
receptor agonist 8-OH-DPAT has established two lines (HDS and
LDS
, respectively) whose behavior differs in a model of depression, but not in the elevated plus-maze test of anxiety. The lines also differed in postsynaptic, but not presynaptic,
5-HT1A
receptors. Based on previous evidence that postsynaptic
5-HT1A
receptors mediate anxiogenic effects in the social interaction test of anxiety, but not the elevated plus-maze, we investigated possible differences between the lines in these two tests. The HDS line had a consistently lower level of social interaction compared with the
LDS
line, but no differences were found on any of the measures of the anxiety on trials 1 or 2 in the elevated plus-maze. To determine whether the line differences in anxiety were mediated by different hippocampal
5-HT1A
receptor function, 8-OH-DPAT (50 and 100 ng) was applied bilaterally to the dorsal hippocampus. This elicited anxiogenic effects in the
LDS
line, as has been previously reported in other rat strains, but there was no response in the HDS line, thus demonstrating an abnormal
5-HT1A
receptor function in the hippocampus. The
5-HT1A
receptor antagonist WAY100635 (200 ng) was administered to the dorsal hippocampus to test for possible differences between the lines in 5-HT tone. There were no significant changes in social interaction in either the HDS or
LDS
rats, indicating that the different level of anxiety between lines is not due to differences in hippocampal 5-HT tone. It is proposed that the HDS line may prove a useful model of a type of high trait anxiety linked to a susceptibility to depression.
...
PMID:Selectively bred lines of rats differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression? 958 32
Selective breeding for high and low sensitivity to the hypothermic response induced by the
5-HT1A
receptor agonist 8- OH-DPAT has established two lines of rat (HDS and
LDS
, respectively) whose behavior differs in a model of depression and in the social interaction test of anxiety. The HDS line has a higher level of anxiety and, furthermore, does not display the usual anxiogenic response to intrahippocampal administration of 8-OH-DPAT. It was therefore hypothesized that this line of rat might be a useful model of high trait anxiety with a susceptibility to depression. We thus investigated whether chronic treatment with fluoxetine would result in an anxiolytic effect in the social interaction test in the
LDS
and HDS lines of rat. In both lines, acute fluoxetine (10 mg/kg) produced an anxiogenic effect in the social interaction test; when rats were tested 24 h after 14 days of fluoxetine treatment there were no anxiolytic effects in either line. In the social interaction test, chronic fluoxetine treatment did not change either the anxiogenic effect of 8-OH-DPAT (100 ng) injected bilaterally into the dorsal hippocampus in the
LDS
line or the lack of response in the HDS line. In the elevated plus-maze, chronic fluoxetine treatment resulted in a significant anxiogenic effect in the HDS line, but was without effect in the
LDS
line. Intrahippocampal 8-OH-DPAT was without effect in the plus-maze in either line. These results suggest that chronic treatment with fluoxetine did not modify the hippocampal
5-HT1A
receptor in either line. The anxiogenic effects observed in the plus-maze in the HDS line after chronic fluoxetine might relate to line differences in
5-HT1A
receptors in other brain regions.
...
PMID:Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function. 1020 75